How “hybrid” surgery can treat complex precordial disease

  In May this year, Mr. Luo, who was extremely weak, came from Yibin to Luzhou Medical Hospital for medical treatment, according to Luzhou Evening News Medical New Line. He had difficulty breathing and hemoptysis, and thought it was just a minor lung problem. However, after a thorough examination, it turned out that Mr. Luo was suffering from complex congenital heart disease, tetralogy of Fallot, combined with a large number of collateral blood vessel formation in the lungs, which is considered a serious heart disease.  Usually, the best time to operate is before two years old, but Mr. Luo was already 37 years old when he arrived at the hospital. If the conventional extracorporeal circulation is chosen to correct the heart malformation, the possibility of postoperative perfusion lung is very high, and the patient’s life is in danger at any time; if the lung collateral vessels are blocked in internal medicine first, and then surgical radical surgery is performed, the patient’s life is also in danger due to lack of oxygen. Experts from the Department of Thoracic Surgery, Cardiovascular Medicine, and Interventional Medicine of the LMC consulted and unanimously decided to combine medical and surgical procedures on the same operating table to perform a “hybrid” procedure. On the same operating table, medical doctors first blocked the collateral vessels in the lung of Mr. Luo. After the blocking was completed, the cardiac surgeon performed a radical operation on the heart malformation in the shortest possible time with the support of extracorporeal circulation, minimizing the risk of the operation. After several hours of full cooperation from the endosurgeons, Mr. Luo had a successful surgery and was discharged from the hospital cured.  The deputy director of the Department of Thoracic Surgery of the Lu Medical Hospital, Associate Professor Deng Mingbin, told reporters that the combination of medical and surgical treatment of complex congenital heart disease “hybrid” surgery is a new technology carried out this year in the Department of Thoracic Surgery, using a combination of medical and surgical techniques to correct congenital heart disease at the same time, so that patients with complex congenital heart disease can receive timely and effective treatment.